What's making Miami sick? Are there cures? Take a look
This collection of stories examines health challenges facing Miami and potential responses to the issues.
One article discusses the impact of Miami's chlorinated tap water on skin health, offering alternatives like filtered showerheads and micellar water. Another highlights the rise of dengue fever, a mosquito-borne illness prevalent in Florida, urging summer travelers to take preventive measures to avoid bites. A separate report focuses on Alzheimer's research at the University of Miami, where researchers work on understanding the disease's prevalence in Hispanic communities. In a related account, Miami-Dade leaders push for police reform in handling incidents involving mental illness, aiming to prevent tragic outcomes.
Read the stories below.
NO. 1: IS TAP WATER IRRITATING YOUR SKIN? HERE ARE OTHER OPTIONS FOR WASHING
Tap water contains chlorine and other minerals that can hurt your skin. | Published October 23, 2024 | Read Full Story by Leslie Baumann, M.D.
No image found A caretaker, center, offers cafecito to Asustina Valdes Cabrera, left, while she is tested by UHealth medical researcher Dr. Katrina Celis, right, as part of an Alzheimer study during a community outreach event for the John P. Hussman Institute for Human Genomics where UM researchers performed tests, enrolled new participants and took blood samples to a new Biorespository opening at UHealth's campus, at Hora Feliz Adult Day Care on Thursday, January 16, 2025, in Hialeah, Fla. By D.A. Varela
NO. 2: HOW A UM LAB IS UNLOCKING THE SECRETS OF THE BRAIN. IT STARTS WITH A PERSONAL MESSAGE
What to know about the visits. | Published January 24, 2025 | Read Full Story by Michelle Marchante
Miami Florida, June 17, 2024 - Gamaly Hollis looks back to her son's grave after she carefully cleaned it. Gamaly Hollis is the mother of Richard Hollis, a young man who was killed by the police on June 15, 2022. By Jose Iglesias
NO. 3: FATAL SHOOTING PROMPTS MOVE FOR MIAMI-DADE TO REFORM HOW POLICE HANDLE MENTAL ILLNESS CALLS
We have huge challenges with people who have mental illness,' says Miami-Dade Public Defender Carlos Martinez. | Published January 26, 2025 | Read Full Story by Carol Marbin Miller Linda Robertson
No image found Aedes aegypti mosquitoes spread dengue to people through bites.
NO. 4: DENGUE FEVER ON THE RISE. WHAT TO KNOW ABOUT THE MOSQUITO-BORNE ILLNESS IN FLORIDA
Puerto Rico has recorded at least 1,012 cases of dengue so far in 2025, followed by Florida, 50, and the U.S. Virgin Islands, which has 40 recorded cases. | Published March 26, 2025 | Read Full Story by Michelle Marchante
The summary above was drafted with the help of AI tools and edited by journalists in our News division. All stories listed were reported, written and edited by McClatchy journalists.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows
Anavex Life Sciences Corp. (NASDAQ:AVXL) reported a peer-reviewed publication in the journal Neuroscience Letters on Wednesday. The study shows that a pre-treatment with blarcamesine prevented Amyloid beta-induced memory impairment and brain oxidative injury. "This preclinical study is exciting since it clearly demonstrates a preventative effect of blarcamesine in Alzheimer's pathology and potentially might be able to prevent onset of Alzheimer's disease in healthy individuals," said Tangui Maurice, PhD, Research Director at the University of Montpellier, France and author of the placebo-controlled mice developed significant amyloid toxicity in the brains after the toxic Aβ25-35 peptide injection, in animals pre-treated with blarcamesine, significant protection was observed, with less vulnerability to Aβ25-35-induced oxidative stress and less vulnerability to develop learning and memory deficits. The mechanistic confirmation that blarcamesine particularly restores impaired autophagy through SIGMAR1 activation by acting upstream of amyloid and tau pathologies at the molecular level was previously established in vitro and in vivo. Blarcamesine studies demonstrated the effect of enhanced autophagic flux in human cells and in C. elegans, as well as increased proteostasis capacity and ability to promote autophagosome biogenesis, autophagic cargo reception, and lysosome fusion. SIGMAR1 has emerged as a key therapeutic target in the treatment of neurodegenerative disorders. Its activation enhances autophagy, facilitating the degradation of amyloid-beta precursor protein (APP) and helping to normalize Aβ production. SIGMAR1 activation supports neurogenesis, mitigates oxidative stress by reducing reactive oxygen species (ROS), suppresses neuroinflammatory responses, and alleviates Aβ-induced toxicity. It also plays a critical role in maintaining endoplasmic reticulum (ER) integrity and modulating intracellular calcium signaling. Collectively, these effects contribute to restoring cellular homeostasis, rebalancing neural function, and promoting neuroplasticity. In April, Anavex Life Sciences announced that over three years of continuous treatment with blarcamesine (ANAVEX 2-73) demonstrated significant amelioration of clinical decline, showing continued clinical and meaningful benefit for early Alzheimer's disease patients. Price Action: AVXL stock is up 1.59% at $9.59 during the premarket session at the last check on Wednesday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Cheap supplement may protect against Alzheimer's in women
Omega fatty acids, found in certain fish or taken as a supplement, could potentially help ward off Alzheimer's disease in women, a new study suggests. Researchers found that lipids – fat molecules in the body – are different in women with Alzheimer's and those without. But they stressed that more work was needed to see whether 'shifting the lipid composition can influence the biological trajectory' of the disease. Scientists from Kings College London and Queen Mary University London, examined blood samples taken from 841 people, including 306 people with Alzheimer's; 165 with mild cognitive impairment and 370 healthy people. They discovered that there was a noticeable loss of unsaturated fats, including those that contain omega fatty acids, in the blood of women with Alzheimer's disease compared to healthy women, according to the study, which has been published in the journal Alzheimer's and Dementia: The Journal of the Alzheimer's Association. They also noted a steep increase in lipids with saturation – also known as 'unhealthy lipids' – in women with Alzheimer's compared to women without. But there was no difference between these fat molecules between men with, and without, a diagnosis of Alzheimer's – which researchers say could help deepen knowledge about why more women than men are diagnosed with Alzheimer's disease. 'Women are disproportionately impacted by Alzheimer's disease and are more often diagnosed with the disease than men after the age of 80,' said senior author of the study Dr Cristina Legido-Quigley, from King's College London. 'One of the most surprising things we saw when looking at the different sexes was that there was no difference in these lipids in healthy and cognitively impaired men, but for women this picture was completely different. 'The study reveals that Alzheimer's lipid biology is different between the sexes, opening new avenues for research. 'Our study suggests that women should make sure they are getting omega fatty acids in their diet – through fatty fish or via supplements. 'However, we need clinical trials to determine if shifting the lipid composition can influence the biological trajectory of Alzheimer's Disease.' Dr Asger Wretlind, first author of the study from King's College London, said: 'Although this still warrants further research, we were able to detect biological differences in lipids between the sexes in a large cohort, and show the importance of lipids containing omegas in the blood, which has not been done before. 'The results are very striking and now we are looking at how early in life this change occurs in women.' Dr Julia Dudley, head of research at Alzheimer's Research UK, which funded the study along with LundbeckFonden, said: 'In the UK, two in three people living with dementia are women. 'This could be linked to living longer, or other risk factors like social isolation, education, or hormonal changes from the menopause being at play. 'While this study shows that women with Alzheimer's had lower levels of some unsaturated fats compared with men, further work is needed. 'This includes understanding the mechanisms behind this difference and finding out if lifestyle changes, including diet could have a role.' People can consume omega-3 fatty acids by eating fatty fish including salmon, mackerel or sardines, or by taking a supplement. It comes as a separate study found that children who had a diet rich in omega-3 fatty acids may have a reduced risk of short sightedness. The study, published in the British Journal of Ophthalmology, examined data on 1,005 Chinese children aged between six and eight years, including their eye sight and regular surveys about their diet. Overall 28% of children had myopia. Researchers from Hong Kong found that a higher consumption of omega-3 fatty acids was associated with a lower risk of the condition.
Yahoo
2 hours ago
- Yahoo
The popular supplement that could protect women from Alzheimer's disease
Omega fatty acids, found in certain fish or taken as a supplement, could potentially help ward off Alzheimer's disease in women, a new study suggests. Researchers discovered that lipids, fat molecules in the body, are different in women with Alzheimer's compared to those without. Their findings, published in Alzheimer's and Dementia: The Journal of the Alzheimer's Association, revealed a noticeable loss of unsaturated fats, including those containing omega fatty acids, in the blood of women with the disease compared to healthy women. The study, conducted by scientists from King's College London and Queen Mary University London, examined blood samples from 841 people, including 306 people with Alzheimer's, 165 with mild cognitive impairment and 370 healthy people. However, the researchers stressed that more work is needed to determine whether "shifting the lipid composition can influence the biological trajectory" of the disease. In the study, the team noted a steep increase in lipids with saturation – also known as 'unhealthy lipids' – in women with Alzheimer's compared to women without. But there was no difference between these fat molecules between men with, and without, a diagnosis of Alzheimer's, which researchers say could help deepen knowledge about why more women than men are diagnosed with Alzheimer's disease. 'Women are disproportionately impacted by Alzheimer's disease and are more often diagnosed with the disease than men after the age of 80,' said senior author of the study, Dr Cristina Legido-Quigley, from King's College London. 'One of the most surprising things we saw when looking at the different sexes was that there was no difference in these lipids in healthy and cognitively impaired men, but for women, this picture was completely different. 'The study reveals that Alzheimer's lipid biology is different between the sexes, opening new avenues for research. 'Our study suggests that women should make sure they are getting omega fatty acids in their diet – through fatty fish or via supplements. 'However, we need clinical trials to determine if shifting the lipid composition can influence the biological trajectory of Alzheimer's Disease.' Dr Asger Wretlind, first author of the study from King's College London, said: 'Although this still warrants further research, we were able to detect biological differences in lipids between the sexes in a large cohort, and show the importance of lipids containing omegas in the blood, which has not been done before. 'The results are very striking, and now we are looking at how early in life this change occurs in women.' Dr Julia Dudley, head of research at Alzheimer's Research UK, which funded the study along with LundbeckFonden, said: 'In the UK, two in three people living with dementia are women. 'This could be linked to living longer, or other risk factors like social isolation, education, or hormonal changes from the menopause being at play. Early symptoms of Alzheimer's disease NHS In the early stages, the main symptom of Alzheimer's disease is memory lapses. For example, someone with early Alzheimer's disease may: forget about recent conversations or events misplace items forget the names of places and objects have trouble thinking of the right word ask questions repetitively show poor judgement or find it harder to make decisions become less flexible and more hesitant to try new things There are often signs of mood changes, such as increasing anxiety or agitation, or periods of confusion. 'While this study shows that women with Alzheimer's had lower levels of some unsaturated fats compared with men, further work is needed. 'This includes understanding the mechanisms behind this difference and finding out if lifestyle changes, including diet, could have a role.' People can consume omega-3 fatty acids by eating fatty fish, including salmon, mackerel or sardines, or by taking a supplement. It comes as a separate study found that children who had a diet rich in omega-3 fatty acids may have a reduced risk of short-sightedness. The study, published in the British Journal of Ophthalmology, examined data on 1,005 Chinese children aged between six and eight years, including their eyesight and regular surveys about their diet. Overall, 28 per cent of children had myopia. Researchers from Hong Kong found that a higher consumption of omega-3 fatty acids was associated with a lower risk of the condition.
